Water Street and JLL Partners completes merger of CCBR-SYNARC and BioClinica

Water Street Healthcare Partners and JLL Partners said Wednesday that they have completed the merger of CCBR-SYNARC and BioClinica. No financial terms were disclosed. Both Water Street and JLL Partners have named Jeffrey McMullen to serve as chairman of the combined company, which will provide specialty outsourced clinical services.

Water Street sells Medical Specialties Distributors

Water Street Healthcare Partners has sold Stoughton, Mass.-based Medical Specialties Distributors to New Mountain Capital. Water Street partnered with MSD’s management team in 2010 to build the company into the nation’s leading distributor and solutions provider to the growing alternate-site home infusion therapy market.

Water Street appoints Katie Ossman to VP

Water Street Healthcare Partners, a strategic investor focused on the healthcare industry, has appointed Katie Ossman to vice president. Ossman will support Water Street with identifying new investment opportunities, and developing and implementing strategic plans to expand its group of health care companies. Prior to Water Street, Ossman worked as an associate with Avista Capital Partners, where she focused on investments in the health care, consumer and industrials sectors.

Lev, Niles Join Ampersand Capital

Ampersand Capital Partners said Monday that Eric Lev has joined as a partner, while Dana Niles was named CFO and Chief Compliance Officer. John Perkins also joined Ampersand as an operating partner. Lev was most recently at Water Street Healthcare Partners where he served on their investment team. Niles previously was CFO of HighPoint Capital. And Perkins was a senior executive at Talecris Biotherapeutics, an Ampersand portfolio company.

Sarnova Acquires DXE Medical

Sarnova, a specialty distributor of health care products in the emergency medical services and acute care markets, has acquired DXE Medical. DXE is the fifth acquisition Sarnova has completed since Water Street Healthcare Partners invested in the company in 2008.

Water Street to Sell OraPharma to Valeant

Valeant Pharmaceuticals is to acquire OraPharma, an oral health company from Water Street Healthcare Partners, a private equity firm focused exclusively on the health care industry. Total deal value is around $312 million. PRESS RELEASE Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Valeant has agreed to acquire OraPharma, a specialty […]

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget